Patent · US Active

Vectors for expression of biocatalysts

US11634695B2 · kind B2 · utility

1Cited by
106References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2020
Grant dateApr 25, 2023
Priority date
Expiry dateDec 4, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y114/11002
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides engineered proline hydroxylase polypeptides for the production of hydroxylated compounds, polynucleotides encoding the engineered proline hydroxylases, host cells capable of expressing the engineered proline hydroxylases, and methods of using the engineered proline hydroxylases to prepare compounds useful in the production of active pharmaceutical agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.